Anyone who’s set foot in a dispensary likely already knows about sativa and indica, the two base strains of cannabis. Pot enthusiasts are also probably acquainted with THC and CBD, cannabinoids with their own unique properties and medicinal benefits. For PotBotics CEO David Goldstein, these distinctions merely scratch the surface — and his company is eager to dig deep.
If you haven’t heard of CBN, THCv, or any of the other nearly 140 minor cannabinoids that have been identified in the cannabis plant, you may soon. According to Goldstein, they are in fact one of ...read more at http://www.sfweekly.com/news/are-minor-cannabinoids-the-future/
...read more at http://www.sfweekly.com/news/are-minor-cannabinoids-the-future/